Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00015626
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
2001-04-24
Brief Title:
A Clinical Trial to Prevent the Complications of Insulin Resistance Including Type-2 Diabetes
Sponsor:
National Center for Research Resources NCRR
Organization:
National Center for Research Resources NCRR
Study Overview
Official Title:
A Clinical Trial to Prevent the Complications of Insulin Resistance Including Type-2 Diabetes
Status:
COMPLETED
Status Verified Date:
2003-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this study is to aggressively treat insulin resistance and its clinical manifestations when they first appear in childhood and to prevent the subsequent progression towards impaired glucose tolerance and type-2 diabetes In the process of this clinical trial we will learn more about the early manifestations of insulin resistance its treatment and its relationship to obesity and type-2 diabetes through parallel in-vivo and in-vitro studies
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: